{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:47:27Z","timestamp":1785901647421,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fund for Scientific Research","doi-asserted-by":"publisher","award":["T.0008.15"],"award-info":[{"award-number":["T.0008.15"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jbc.2025.108295","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T18:51:16Z","timestamp":1739299876000},"page":"108295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combined deletion of cytosolic 5\u2032-nucleotidases IA and II lowers glycemia by improving skeletal muscle insulin action and lowering hepatic glucose production"],"prefix":"10.1016","volume":"301","author":[{"given":"Roxane","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebtan","family":"Herinckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Galland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Balty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7648-8282","authenticated-orcid":false,"given":"Didier","family":"Vertommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-5949","authenticated-orcid":false,"given":"Manuel","family":"Johanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.108295_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11091","article-title":"AMPK activation is sufficient to increase skeletal muscle glucose uptake and glycogen synthesis but is not required for contraction-mediated increases in glucose metabolism","volume":"8","author":"Esquejo","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.jbc.2025.108295_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1748-1716.2009.01979.x","article-title":"AMP-activated protein kinase in contraction regulation of skeletal muscle metabolism: necessary and\/or sufficient?","volume":"196","author":"Jensen","year":"2009","journal-title":"Acta Physiol. (Oxf)"},{"key":"10.1016\/j.jbc.2025.108295_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BCJ20220582","article-title":"AMPK inhibits liver gluconeogenesis: fact or fiction?","volume":"480","author":"Johanns","year":"2023","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2025.108295_bib4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.chembiol.2014.09.013","article-title":"Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle","volume":"21","author":"Plaideau","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2025.108295_bib5","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1096\/fj.11-198168","article-title":"Overexpression of AMP-metabolizing enzymes controls adenine nucleotide levels and AMPK activation in HEK293T cells","volume":"26","author":"Plaideau","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2025.108295_bib6","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1152\/ajpendo.00304.2016","article-title":"Effects of genetic deletion of soluble 5\u2032-nucleotidases NT5C1A and NT5C2 on AMPK activation and nucleotide levels in contracting mouse skeletal muscles","volume":"313","author":"Kviklyte","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2025.108295_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ymgme.2019.01.017","article-title":"Genetic deletion of soluble 5\u2032-nucleotidase II reduces body weight gain and insulin resistance induced by a high-fat diet","volume":"126","author":"Johanns","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.jbc.2025.108295_bib8","first-page":"23","article-title":"Role of AMPD2 in impaired glucose tolerance induced by high fructose diet","volume":"13","author":"Hudoyo","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.jbc.2025.108295_bib9","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.chembiol.2014.09.011","article-title":"Inhibition of AMP deaminase activity does not improve glucose control in rodent models of insulin resistance or diabetes","volume":"21","author":"Admyre","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2025.108295_bib10","doi-asserted-by":"crossref","first-page":"34567","DOI":"10.1074\/jbc.M111.268292","article-title":"Suppression of 5\u2032-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle","volume":"286","author":"Kulkarni","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108295_bib11","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.3390\/ijms22137004","article-title":"Cytosolic 5\u2032-nucleotidase II silencing in lung tumor cells regulates metabolism through activation of the p53\/AMPK signaling pathway","volume":"22","author":"Pesi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2025.108295_bib12","article-title":"Liver AMP-activated protein kinase is unnecessary for gluconeogenesis but protects energy state during nutrient deprivation","volume":"12","author":"Hasenour","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.108295_bib13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41591-018-0159-7","article-title":"Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase","volume":"24","author":"Hunter","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2025.108295_bib14","series-title":"Amino Acid and Nucleotide Metabolism in Biochemistry","first-page":"345","author":"Stenesh","year":"1998"},{"key":"10.1016\/j.jbc.2025.108295_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/abbi.1999.1133","article-title":"A specific inhibitor of heart cytosolic 5\u2032-nucleotidase I attenuates hydrolysis of adenosine 5\u2032-monophosphate in primary rat myocytes","volume":"364","author":"Garvey","year":"1999","journal-title":"Arch Biochem Biophys."},{"key":"10.1016\/j.jbc.2025.108295_bib16","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1158\/2159-8290.CD-22-0010","article-title":"Pharmacologic inhibition of NT5C2 reverses genetic and nongenetic drivers of 6-MP resistance in acute lymphoblastic leukemia","volume":"12","author":"Reglero","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2025.108295_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4236\/jbise.2014.71006","article-title":"Purine nucleotides and their metabolites in patients with type 1 and 2 diabetes mellitus","volume":"7","author":"Dudzinska","year":"2014","journal-title":"J.\u00a0Biomed. Sci. Eng."},{"key":"10.1016\/j.jbc.2025.108295_bib18","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1210\/jc.2019-00822","article-title":"Purine metabolites and carnitine biosynthesis intermediates are biomarkers for incident type 2 diabetes","volume":"104","author":"Ottosson","year":"2019","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2025.108295_bib19","first-page":"54","article-title":"Relevance of uric Acid in progression of type 2 diabetes mellitus","volume":"10","author":"Causevic","year":"2010","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.jbc.2025.108295_bib20","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1038\/s41598-019-39441-6","article-title":"Metabolites related to purine catabolism and risk of type 2 diabetes incidence; modifying effects of the TCF7L2-rs7903146 polymorphism","volume":"9","author":"Papandreou","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.108295_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imlet.2018.11.006","article-title":"Extracellular nucleotides and nucleosides as signalling molecules","volume":"205","author":"Giuliani","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jbc.2025.108295_bib22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1146\/annurev-biochem-011520-105201","article-title":"Structural and mechanistic principles of ABC transporters","volume":"89","author":"Thomas","year":"2020","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2025.108295_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1042\/BST20160038","article-title":"The SLC28 (CNT) and SLC29 (ENT) nucleoside transporter families: a 30-year collaborative odyssey","volume":"44","author":"Young","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jbc.2025.108295_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114393","article-title":"Purinergic signaling in diabetes and metabolism","volume":"187","author":"Jain","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2025.108295_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2015.10","article-title":"Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations","volume":"11","author":"Antonioli","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jbc.2025.108295_bib26","article-title":"ATP secretion and metabolism in regulating pancreatic beta cell functions and hepatic glycolipid metabolism","volume":"13","author":"Li","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jbc.2025.108295_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2014.04.080","article-title":"High uric acid directly inhibits insulin signalling and induces insulin resistance","volume":"447","author":"Zhu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2025.108295_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.celrep.2015.08.072","article-title":"Adenylosuccinate is an insulin secretagogue derived from glucose-induced purine","volume":"13","author":"Gooding","year":"2015","journal-title":"Metab. Cell Rep."},{"key":"10.1016\/j.jbc.2025.108295_bib29","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1152\/ajpendo.00487.2003","article-title":"Possible involvement of the alpha1 isoform of 5\u2032AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle","volume":"287","author":"Toyoda","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.jbc.2025.108295_bib30","doi-asserted-by":"crossref","first-page":"33988","DOI":"10.1074\/jbc.M805224200","article-title":"Mammalian phosphomannomutase PMM1 is the brain IMP-sensitive glucose-1,6-bisphosphatase","volume":"283","author":"Veiga-da-Cunha","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108295_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbrc.2009.06.040","article-title":"Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity","volume":"386","author":"Su","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2025.108295_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123096","article-title":"Hypoxanthine ameliorates diet-induced insulin resistance by improving hepatic lipid metabolism and gluconeogenesis via AMPK\/mTOR\/PPAR\u03b1 pathway","volume":"357","author":"Huang","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.jbc.2025.108295_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fimmu.2019.00745","article-title":"Anti-NT5c1A autoantibodies as biomarkers in inclusion body myositis","volume":"10","author":"Amlani","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2025.108295_bib34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ebiom.2019.01.037","article-title":"Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites","volume":"40","author":"Patzak","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jbc.2025.108295_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41525-017-0022-7","article-title":"Whole genome sequencing identifies a novel homozygous exon deletion in the NT5C2 gene in a family with intellectual disability and spastic paraplegia","volume":"2","author":"Darvish","year":"2017","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/j.jbc.2025.108295_bib36","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood-2019-01-852392","article-title":"Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL","volume":"133","author":"Dieck","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.108295_bib37","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1158\/0008-5472.CAN-23-3804","article-title":"An alternatively spliced gain-of-function NT5C2 isoform contributes to chemoresistance in acute lymphoblastic","volume":"84","author":"Torres-Diz","year":"2024","journal-title":"Leuk. Cancer Res."},{"key":"10.1016\/j.jbc.2025.108295_bib38","doi-asserted-by":"crossref","first-page":"67380","DOI":"10.18632\/oncotarget.18653","article-title":"The cytosolic 5'-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells","volume":"8","author":"Bricard","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2025.108295_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114102","article-title":"Discovery of small molecules interacting at lactate dehydrogenases tetrameric interface using a biophysical screening cascade","volume":"230","author":"Thabault","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2025.108295_bib40","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jmb.2011.02.059","article-title":"Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5'-nucleotidase II","volume":"408","author":"Walld\u00e9n","year":"2011","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2025.108295_bib41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1042\/BCJ20220170","article-title":"Inhibition of basal and glucagon-induced hepatic glucose production by 991 and other pharmacological AMPK activators","volume":"479","author":"Johanns","year":"2022","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2025.108295_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10856","article-title":"AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B","volume":"7","author":"Johanns","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.108295_bib43","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ng1796","article-title":"Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus","volume":"38","author":"Clee","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2025.108295_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03593-22","article-title":"Transcriptional and translational dynamics underlying heat shock response in the thermophilic crenarchaeon Sulfolobus acidocaldarius","volume":"14","author":"Baes","year":"2023","journal-title":"mBio"}],"updated-by":[{"DOI":"10.1016\/j.jbc.2025.110955","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825001437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825001437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:41:04Z","timestamp":1768970464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825001437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0021925825001437"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108295","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.09.632106","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined deletion of cytosolic 5\u2032-nucleotidases IA and II lowers glycemia by improving skeletal muscle insulin action and lowering hepatic glucose production","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"108295"}}